OKTA vs QNRX · P/E 84, rev $1.57B vs $9.6M cap
Okta Inc (OKTA) versus Quoin Pharmaceuticals Ltd DRC (QNRX) — a side-by-side from cached financials, not a winner call.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Quoin Pharmaceuticals Ltd DRC (QNRX) is a biotechnology company listed on NASDAQ.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
QNRX does not have a complete income-statement cache yet.
OKTA currently screens at market cap $20.06B and trailing P/E 83.6. QNRX currently screens at market cap $9.6M.
Not investment advice. Open the OKTA and QNRX stock pages for the full models.
Not investment advice.